Thomas Jefferson University

David Harris

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA048085     (HARRIS, DAVID T)Jul 15, 1988 - Jun 30, 1994
    NIH
    ANALYSIS OF A NATURAL KILLER CELL TARGET CELL ANTIGEN
    Role: Principal Investigator
    R01AG038021     (HARRIS, DAVID THOMAS)Sep 1, 2010 - Aug 31, 2015
    NIH
    Role of Extrinsic and Intrinsic Factors Responsible for Aging of Immune System
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Harris DT, Jan CH. CRISPuRe-seq: pooled screening of barcoded ribonucleoprotein reporters reveals regulation of RNA polymerase III transcription by the integrated stress response via mTOR. Nucleic Acids Res. 2025 Feb 08; 53(4). PMID: 39970294.
      Citations:    
    2. Harris DT, Jan CH. CRISPuRe-seq: pooled screening of barcoded ribonucleoprotein reporters reveals regulation of RNA polymerase III transcription by the integrated stress response via mTOR. Nucleic Acids Res. 2025 Feb 08; 53(4). PMID: 39921565.
      Citations:    
    3. Harris DT, Badowski M. iPSC stem cell banks: is it really necessary if we already have cord blood banks? Regen Med. 2025 Jan; 20(1):17-20. PMID: 39815772.
      Citations:    
    4. Jia W, Li H, Ali R, Shanbhogue KP, Masch WR, Aslam A, Harris DT, Reeder SB, Dillman JR, He L. Investigation of ComBat Harmonization on Radiomic and Deep Features from Multi-Center Abdominal MRI Data. J Imaging Inform Med. 2024 Sep 16. PMID: 39284979.
      Citations:    
    5. Buelo CJ, Velikina J, Mao L, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5?T and 3?T. Magn Reson Med. 2024 Sep 05. PMID: 39238238.
      Citations:    
    6. Choudhery MS, Arif T, Mahmood R, Harris DT. Stem Cell-Based Acellular Therapy: Insight into Biogenesis, Bioengineering and Therapeutic Applications of Exosomes. Biomolecules. 2024 Jul 03; 14(7). PMID: 39062506.
      Citations:    
    7. Choudhery MS, Arif T, Mahmood R, Harris DT. CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects. J Clin Med. 2024 May 29; 13(11). PMID: 38892913.
      Citations:    
    8. Simchick G, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, do Vale Souza R, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5?T and 3.0?T. J Magn Reson Imaging. 2024 Apr 25. PMID: 38662618.
      Citations:    
    9. Harris DT, Ingraham N, Badowski M. Comparison of Manual versus Automated SARS-CoV-2 Rapid Antigen Testing in Asymptomatic Individuals. J Clin Med. 2023 Nov 17; 12(22). PMID: 38002757.
      Citations:    
    10. Shamim AMKM, Panagiotopoulos N, Spahic A, Harris DT, Rold?n-Alzate A, Wieben O, Reeder SB, Oechtering TH, Johnson KM. Fat mitigation strategies to improve image quality of radial 4D flow MRI in obese subjects. Magn Reson Med. 2023 Apr 10. PMID: 37036023.
      Citations:    
    11. Hernando D, Zhao R, Yuan Q, Aliyari Ghasabeh M, Ruschke S, Miao X, Karampinos DC, Mao L, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology. 2023 Feb; 306(2):e213256. PMID: 36194113.
      Citations:    
    12. Choudhery MS, Mahmood R, Harris DT, Ahmad FJ. Minimum criteria for defining induced mesenchymal stem cells. Cell Biol Int. 2022 Jun; 46(6):986-989. PMID: 35293653.
      Citations:    
    13. Muise A, White L, Badowski M, Harris DT. Analysis of High-Throughput Processing Methods for Peripheral Blood Cell Isolation. Biopreserv Biobank. 2022 06; 20(3):302-305. PMID: 35085446.
      Citations:    
    14. Zhao R, Hernando D, Harris DT, Hinshaw LA, Li K, Ananthakrishnan L, Bashir MR, Duan X, Ghasabeh MA, Kamel IR, Lowry C, Mahesh M, Marin D, Miller J, Pickhardt PJ, Shaffer J, Yokoo T, Brittain JH, Reeder SB. Multisite multivendor validation of a quantitative MRI and CT compatible fat phantom. Med Phys. 2021 Aug; 48(8):4375-4386. PMID: 34105167.
      Citations:    
    15. Harris DT, Badowski M, Jernigan B, Sprissler R, Edwards T, Cohen R, Paul S, Merchant N, Weinkauf CC, Bime C, Erickson HE, Bixby B, Parthasarathy S, Chaudhary S, Natt B, Cristan E, El Aini T, Rischard F, Campion J, Chopra M, Insel M, Sam A, Knepler JL, Knox K, Mosier J, Spier C, Dake MD. SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus. Biomedicines. 2021 May 12; 9(5). PMID: 34066047.
      Citations:    
    16. Betancourt WQ, Schmitz BW, Innes GK, Prasek SM, Pogreba Brown KM, Stark ER, Foster AR, Sprissler RS, Harris DT, Sherchan SP, Gerba CP, Pepper IL. COVID-19 containment on a college campus via wastewater-based epidemiology, targeted clinical testing and an intervention. Sci Total Environ. 2021 Jul 20; 779:146408. PMID: 33743467.
      Citations:    
    17. Ripperger TJ, Uhrlaub JL, Watanabe M, Wong R, Castaneda Y, Pizzato HA, Thompson MR, Bradshaw C, Weinkauf CC, Bime C, Erickson HL, Knox K, Bixby B, Parthasarathy S, Chaudhary S, Natt B, Cristan E, El Aini T, Rischard F, Campion J, Chopra M, Insel M, Sam A, Knepler JL, Capaldi AP, Spier CM, Dake MD, Edwards T, Kaplan ME, Scott SJ, Hypes C, Mosier J, Harris DT, LaFleur BJ, Sprissler R, Nikolich-?ugich J, Bhattacharya D. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity. Immunity. 2020 11 17; 53(5):925-933.e4. PMID: 33129373.
      Citations:    
    18. Choudhery MS, Harris DT. Stem cell therapy for COVID-19: Possibilities and challenges. Cell Biol Int. 2020 Nov; 44(11):2182-2191. PMID: 32767687.
      Citations:    
    19. Ripperger TJ, Uhrlaub JL, Watanabe M, Wong R, Castaneda Y, Pizzato HA, Thompson MR, Bradshaw C, Weinkauf CC, Bime C, Erickson HL, Knox K, Bixby B, Parthasarathy S, Chaudhary S, Natt B, Cristan E, Aini TE, Rischard F, Campion J, Chopra M, Insel M, Sam A, Knepler JL, Capaldi AP, Spier CM, Dake MD, Edwards T, Kaplan ME, Scott SJ, Hypes C, Mosier J, Harris DT, LaFleur BJ, Sprissler R, Nikolich-?ugich J, Bhattacharya D. Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure. medRxiv. 2020 Aug 15. PMID: 32817969.
      Citations:    
    20. Valori V, Tus K, Laukaitis C, Harris DT, LeBeau L, Maggert KA. Human rDNA copy number is unstable in metastatic breast cancers. Epigenetics. 2020 Jan - Feb; 15(1-2):85-106. PMID: 31352858.
      Citations:    
    21. Badowski MS, Muise A, Harris DT. Long-Term Biobanking of Intact Tissue from Lipoaspirate. J Clin Med. 2019 Mar 08; 8(3). PMID: 30857129.
      Citations:    
    22. Harris DT, Israel S. What will Become of the Taxpayer Investment in Public Cord Blood Stem Cell Banking? Curr Stem Cell Res Ther. 2019; 14(4):367-372. PMID: 30806326.
      Citations:    
    23. Harris DT. Biobanking and Regenerative Medicine: An Overview. J Clin Med. 2018 May 31; 7(6). PMID: 29857481.
      Citations:    
    24. Pandey AC, Lancaster JJ, Harris DT, Goldman S, Juneman E. Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells. Stem Cells Int. 2017; 2017:9640108. PMID: 29391871.
      Citations:    
    25. Harris DT. Banking of Adipose- and Cord Tissue-Derived Stem Cells: Technical and Regulatory Issues. Adv Exp Med Biol. 2016; 951:147-154. PMID: 27837561.
      Citations:    
    26. Harris DT, Kallman BR, Mullaney BC, Scott K. Representations of Taste Modality in the Drosophila Brain. Neuron. 2015 Jun 17; 86(6):1449-60. PMID: 26051423.
      Citations:    
    27. Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Subcutaneous Adipose Tissue-Derived Stem Cell Utility Is Independent of Anatomical Harvest Site. Biores Open Access. 2015; 4(1):131-45. PMID: 26309790.
      Citations:    
    28. Corenblum MJ, Flores AJ, Badowski M, Harris DT, Madhavan L. Systemic human CD34(+) cells populate the brain and activate host mechanisms to counteract nigrostriatal degeneration. Regen Med. 2015; 10(5):563-77. PMID: 26237701.
      Citations:    
    29. Choudhery MS, Badowski M, Muise A, Harris DT. Effect of mild heat stress on the proliferative and differentiative ability of human mesenchymal stromal cells. Cytotherapy. 2015 Apr; 17(4):359-68. PMID: 25536863.
      Citations:    
    30. Choudhery MS, Harris DT. Cryopreservation can be used as an anti-aging strategy. Cytotherapy. 2014 Dec; 16(12):1771-3. PMID: 25304665.
      Citations:    
    31. Badowski M, Muise A, Harris DT. Mixed effects of long-term frozen storage on cord tissue stem cells. Cytotherapy. 2014 Sep; 16(9):1313-21. PMID: 25108655.
      Citations:    
    32. Li H, Feng Z, Tsang TC, Tang T, Jia X, He X, Pennington ME, Badowski MS, Liu AK, Chen D, Harris DT, Martinez J, Meade-Tollin LC. Fusion of HepG2 cells with mesenchymal stem cells increases cancer-associated and malignant properties: an in vivo metastasis model. Oncol Rep. 2014 Aug; 32(2):539-47. PMID: 24926698.
      Citations:    
    33. Badowski M, Shultz C, Harris DT. WITHDRAWN: Effect of anti-coagulant choice on cord blood processing results. Cytotherapy. 2014 Jun 11. PMID: 24927714.
      Citations:    
    34. Badowski M, Shultz CL, Eason Y, Ahmad N, Harris DT. The influence of intrinsic and extrinsic factors on immune system aging. Immunobiology. 2014 Jun; 219(6):482-5. PMID: 24661721.
      Citations:    
    35. Harris DT. Stem Cell Banking for Regenerative and Personalized Medicine. Biomedicines. 2014 Feb 26; 2(1):50-79. PMID: 28548060.
      Citations:    
    36. Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med. 2014 Jan 07; 12:8. PMID: 24397850.
      Citations:    
    37. Harris DT, Badowski M, Balamurugan A, Yang OO. Long-term human immune system reconstitution in non-obese diabetic (NOD)-Rag (-)-? chain (-) (NRG) mice is similar but not identical to the original stem cell donor. Clin Exp Immunol. 2013 Dec; 174(3):402-13. PMID: 24032450.
      Citations:    
    38. Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Cryopreservation of whole adipose tissue for future use in regenerative medicine. J Surg Res. 2014 Mar; 187(1):24-35. PMID: 24268882.
      Citations:    
    39. Harris DT, Badowski M. Long term human reconstitution and immune aging in NOD-Rag (-)-? chain (-) mice. Immunobiology. 2014 Feb; 219(2):131-7. PMID: 24094417.
      Citations:    
    40. Choudhery MS, Badowski M, Muise A, Harris DT. Utility of cryopreserved umbilical cord tissue for regenerative medicine. Curr Stem Cell Res Ther. 2013 Sep; 8(5):370-80. PMID: 23755729.
      Citations:    
    41. Harris DT. Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. Curr Stem Cell Res Ther. 2013 Sep; 8(5):394-9. PMID: 23895058.
      Citations:    
    42. Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy. 2013 Mar; 15(3):330-43. PMID: 23318344.
      Citations:    
    43. Harris DT. Is volume the only factor that impacts cord blood processing efficiency? Cytotherapy. 2012 Sep; 14(8):1022-3. PMID: 22624698.
      Citations:    
    44. Harris DT, Hilgaertner J, Simonson C, Ablin RJ, Badowski M. Cell-based therapy for epithelial wounds. Cytotherapy. 2012 Aug; 14(7):802-10. PMID: 22458955.
      Citations:    
    45. Harris DT. Alterations in target cell membrane phospholipids alter T cell but not NK cell killing. Immunobiology. 2013 Jan; 218(1):21-7. PMID: 22349517.
      Citations:    
    46. Badowski MS, Harris DT. Collection, processing, and banking of umbilical cord blood stem cells for transplantation and regenerative medicine. Methods Mol Biol. 2012; 879:279-90. PMID: 22610565.
      Citations:    
    47. Harris DT. Optimizing cord blood sample cryopreservation. Cytotherapy. 2012 Mar; 14(3):359-65. PMID: 22175912.
      Citations:    
    48. Harris DT. Changes in plasma membrane phospholipids inhibit antibody-mediated lysis. Biochem Biophys Res Commun. 2012 Jan 06; 417(1):231-6. PMID: 22142842.
      Citations:    
    49. Harris DT, Horvitz HR. MAB-10/NAB acts with LIN-29/EGR to regulate terminal differentiation and the transition from larva to adult in C. elegans. Development. 2011 Sep; 138(18):4051-62. PMID: 21862562.
      Citations:    
    50. Hurschler BA, Harris DT, Grosshans H. The type II poly(A)-binding protein PABP-2 genetically interacts with the let-7 miRNA and elicits heterochronic phenotypes in Caenorhabditis elegans. Nucleic Acids Res. 2011 Jul; 39(13):5647-57. PMID: 21415013.
      Citations:    
    51. Hilgaertner JW, He X, Camacho D, Badowski M, Witten M, Harris DT. The influence of hydrocarbon composition and exposure conditions on jet fuel-induced immunotoxicity. Toxicol Ind Health. 2011 Nov; 27(10):887-98. PMID: 21402657.
      Citations:    
    52. Ahmad N, Mehta R, Harris DT. HIV-1 replication and gene expression occur at higher levels in neonatal blood naive and memory T-lymphocytes compared with adult blood cells. Virology. 2011 Apr 25; 413(1):39-46. PMID: 21353282.
      Citations:    
    53. Nietfeld JJ, Harris DT. Cost-effectiveness of private umbilical cord blood banking. Obstet Gynecol. 2010 May; 115(5):1090. PMID: 20410795.
      Citations:    
    54. Sundaravaradan V, Mehta R, Harris DT, Zack JA, Ahmad N. Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells. Virology. 2010 Apr 25; 400(1):32-43. PMID: 20138641.
      Citations:    
    55. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009 Oct; 147(2):177-84. PMID: 19796266.
      Citations:    
    56. Badowski MS, Zhang T, Tsang TC, Harris DT. Chimeric antigen receptors for stem cell based immunotherapy. J Exp Ther Oncol. 2009; 8(1):53-63. PMID: 19827271.
      Citations:    
    57. Wellensiek BP, Ramakrishnan R, Sundaravaradan V, Mehta R, Harris DT, Ahmad N. Differential HIV-1 integration targets more actively transcribed host genes in neonatal than adult blood mononuclear cells. Virology. 2009 Mar 01; 385(1):28-38. PMID: 19100594.
      Citations:    
    58. Harris DT. Cord blood stem cells: worth the investment. Nat Rev Cancer. 2008 Oct; 8(10):823; author reply 823. PMID: 18813324.
      Citations:    
    59. Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008 Dec; 4(4):269-74. PMID: 18679834.
      Citations:    
    60. Harris DT, Sakiestewa D, Titone D, He X, Hyde J, Witten M. JP-8 jet fuel exposure suppresses the immune response to viral infections. Toxicol Ind Health. 2008 May; 24(4):209-16. PMID: 19022873.
      Citations:    
    61. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007 Dec; 2(4):301-9. PMID: 18220914.
      Citations:    
    62. Harris DT, Sakiestewa D, Titone D, He X, Hyde J, Witten M. JP-8 jet fuel exposure potentiates tumor development in two experimental model systems. Toxicol Ind Health. 2007 Nov; 23(10):617-23. PMID: 18717520.
      Citations:    
    63. Andrus MB, Christiansen MA, Hicken EJ, Gainer MJ, Bedke DK, Harper KC, Mikkelson SR, Dodson DS, Harris DT. Phase-transfer-catalyzed asymmetric acylimidazole alkylation. Org Lett. 2007 Nov 08; 9(23):4865-8. PMID: 17944480.
      Citations:    
    64. Davis AH, Tsang TC, Harris DT. Direct sequencing is more accurate and feasible in detecting single nucleotide polymorphisms than RFLP: using human vascular endothelial growth factor gene as a model. Biol Res Nurs. 2007 Oct; 9(2):170-8. PMID: 17909169.
      Citations:    
    65. Harris DT, Sakiestewa D, He X, Titone D, Witten M. Effects of in utero JP-8 jet fuel exposure on the immune systems of pregnant and newborn mice. Toxicol Ind Health. 2007 Oct; 23(9):545-52. PMID: 18681240.
      Citations:    
    66. Harris DT, Badowski M, Ahmad N, Gaballa MA. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther. 2007 Sep; 7(9):1311-22. PMID: 17727322.
      Citations:    
    67. Harris DT, Sakiestewa D, Titone D, Witten M. JP-8 jet fuel exposure rapidly induces high levels of IL-10 and PGE2 secretion and is correlated with loss of immune function. Toxicol Ind Health. 2007 May; 23(4):223-30. PMID: 18429382.
      Citations:    
    68. Cohen-Barak O, Erickson DT, Badowski MS, Fuchs DA, Klassen CL, Harris DT, Brilliant MH. Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult mice. Exp Hematol. 2007 Mar; 35(3):358-67. PMID: 17309816.
      Citations:    
    69. Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy. Stem Cells Dev. 2007 Feb; 16(1):177-86. PMID: 17348813.
      Citations:    
    70. Luo P, Reed BD, Tsang TC, Harris DT, Flavell RA. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines. DNA Cell Biol. 2006 Dec; 25(12):659-67. PMID: 17184167.
      Citations:    
    71. Dammeyer P, Jaramillo MC, Pipes BL, Badowski MS, Tsang TC, Harris DT. Heat-inducible amplifier vector for high-level expression of granulocyte-macrophage colony-stimulating factor. Int J Hyperthermia. 2006 Aug; 22(5):407-19. PMID: 16891243.
      Citations:    
    72. Sundaravaradan V, Saxena SK, Ramakrishnan R, Yedavalli VR, Harris DT, Ahmad N. Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Proc Natl Acad Sci U S A. 2006 Aug 01; 103(31):11701-6. PMID: 16868088.
      Citations:    
    73. Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT. Telomere length changes after umbilical cord blood transplant. Transfusion. 2006 Jun; 46(6):1038-43. PMID: 16734822.
      Citations:    
    74. Luo P, Tsang TC, He X, Gonzalez-Pena V, Jaramillo M, Takeuchi C, Harris DT. Novel amplifier expression vectors producing higher levels of IL-2 led to slower tumor growth and longer survival in vivo. DNA Cell Biol. 2005 Sep; 24(9):595-604. PMID: 16153160.
      Citations:    
    75. He X, Gonzalez V, Tsang A, Thompson J, Tsang TC, Harris DT. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev. 2005 Apr; 14(2):188-98. PMID: 15910245.
      Citations:    
    76. He X, Tsang TC, Zhang T, Luo P, Harris DT. Antigen epitope-expressing cytokines for DNA immunization. Vaccine. 2005 Mar 14; 23(16):1966-72. PMID: 15734069.
      Citations:    
    77. He X, Luo P, Tsang TC, Zhang T, Harris DT. Immuno-gene therapy of melanoma by tumor antigen epitope modified IFN-gamma. Cancer Immunol Immunother. 2005 Aug; 54(8):741-9. PMID: 15726359.
      Citations:    
    78. He X, Tsang TC, Pipes BL, Ablin RJ, Harris DT. A stem cell fusion model of carcinogenesis. J Exp Ther Oncol. 2005; 5(2):101-9. PMID: 16471036.
      Citations:    
    79. Lebsack TW, Kreulen C, Deever DB, Harris DT, Witten ML. Substance P effects on developing thymocytes in hindlimb unloaded rats. Aviat Space Environ Med. 2005 Jan; 76(1):11-8. PMID: 15672981.
      Citations:    
    80. Pipes BL, Vasanwala FH, Tsang TC, Zhang T, Luo P, Harris DT. Brief heat shock increases stable integration of lipid-mediated DNA transfections. Biotechniques. 2005 Jan; 38(1):48, 50, 52. PMID: 15679084.
      Citations:    
    81. Zhang T, He X, Tsang TC, Harris DT. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 2004 Jul; 11(7):487-96. PMID: 15153936.
      Citations:    
    82. Laurencon A, Orme CM, Peters HK, Boulton CL, Vladar EK, Langley SA, Bakis EP, Harris DT, Harris NJ, Wayson SM, Hawley RS, Burtis KC. A large-scale screen for mutagen-sensitive loci in Drosophila. Genetics. 2004 May; 167(1):217-31. PMID: 15166149.
      Citations:    
    83. Luo P, He X, Tsang TC, Harris DT. A novel inducible amplifier expression vector for high and controlled gene expression. Int J Mol Med. 2004 Feb; 13(2):319-25. PMID: 14719141.
      Citations:    
    84. Zhang T, He X, Tsang TC, Harris DT. SING: a novel strategy for identifying tumor-specific, CTL-recognized tumor antigens. FASEB J. 2004 Mar; 18(3):600-2. PMID: 14734636.
      Citations:    
    85. He X, Tsang TC, Luo P, Zhang T, Harris DT. Enhanced tumor immunogenicity through coupling cytokine expression with antigen presentation. Cancer Gene Ther. 2003 Sep; 10(9):669-77. PMID: 12944986.
      Citations:    
    86. Birebent B, Mitchell E, Akis N, Li W, Somasundaram R, Purev E, Hoey D, Mastrangelo M, Maguire H, Harris DT, Nair S, Cai D, Zhang T, Herlyn DM. Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients. Vaccine. 2003 Apr 2; 21(15):1601-12. PMID: 12639481.
      Citations:    
    87. Harris DT, Witten M. Aerosolized substance P protects against cigarette-induced lung damage and tumor development. Cell Mol Biol (Noisy-le-grand). 2003 Mar; 49(2):151-7. PMID: 12887098.
      Citations:    
    88. Zhang T, Tsang TC, Harris DT. Efficient transduction of murine primary T cells requires a combination of high viral titer, preferred tropism, and proper timing of transduction. J Hematother Stem Cell Res. 2003 Feb; 12(1):123-30. PMID: 12662443.
      Citations:    
    89. Zhang T, Tsang TC, Harris DT. Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors. Biotechniques. 2002 Nov; 33(5):1146-51. PMID: 12449396.
      Citations:    
    90. Luo P, Tsang TC, Takeuchi C, Dekker J, Badowski M, Harris DT. High-efficiency cloning system for versatile adaptation of DNA fragments. Biotechniques. 2002 Oct; 33(4):738, 740, 742. PMID: 12398178.
      Citations:    
    91. Harris DT, Sakiestewa D, Titone D, Young RS, Witten M. JP-8 jet fuel exposure results in immediate immunotoxicity, which is cumulative over time. Toxicol Ind Health. 2002 Mar; 18(2):77-83. PMID: 12868796.
      Citations:    
    92. Shibata A, Harris DT, Billings PR. Concentrations of estrogens and IGFs in umbilical cord blood plasma: a comparison among Caucasian, Hispanic, and Asian-American females. J Clin Endocrinol Metab. 2002 Feb; 87(2):810-5. PMID: 11836326.
      Citations:    
    93. Birebent B, Koido T, Mitchell E, Li W, Somasundaram R, Purev E, Hoey D, Mastrangelo M, Maguire H, Harris DT, Nair S, Cai E, Herlyn D. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients. J Cancer Res Clin Oncol. 2001 Oct; 127 Suppl 2:R27-33. PMID: 11768621.
      Citations:    
    94. Birebent B, Somasundaram R, Purev E, Li W, Mitchell E, Hoey D, Bloom E, Mastrangelo M, Maguire H, Harris DT, Staib L, Braumuller H, Leeser C, Kuttner N, Beger HG, Herlyn D. Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients. Crit Rev Oncol Hematol. 2001 Jul-Aug; 39(1-2):107-13. PMID: 11418307.
      Citations:    
    95. Harris DT. Introduction: The evolution of early systemic therapy. Semin Oncol. 2001 Feb; 28(1):1-2. PMID: 11254862.
      Citations:    
    96. Harris DT, Sakiestewa D, Titone D, Robledo RF, Young RS, Witten M. Jet fuel-induced immunotoxicity. Toxicol Ind Health. 2000 Sep; 16(7-8):261-5. PMID: 11693943.
      Citations:    
    97. Harris DT, Sakiestewa D, Titone D, Robledo RF, Young RS, Witten M. Substance P as prophylaxis for JP-8 jet fuel-induced immunotoxicity. Toxicol Ind Health. 2000 Sep; 16(7-8):253-9. PMID: 11693942.
      Citations:    
    98. Meidenbauer N, Harris DT, Spitler LE, Whiteside TL. Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer. Prostate. 2000 May 01; 43(2):88-100. PMID: 10754524.
      Citations:    
    99. Tsang TC, Brailey JL, Vasanwala FH, Wu RS, Liu F, Clark PR, Meade-Tollin L, Luznick L, Stopeck AT, Akporiaye ET, Harris DT. Construction of new amplifier expression vectors for high levels of IL-2 gene expression. Int J Mol Med. 2000 Mar; 5(3):295-300. PMID: 10677573.
      Citations:    
    100. Harris DT, Sakiestewa D, Robledo RF, Young RS, Witten M. Effects of short-term JP-8 jet fuel exposure on cell-mediated immunity. Toxicol Ind Health. 2000 Feb; 16(2):78-84. PMID: 10798625.
      Citations:    
    101. Harris DT, Matyas GR, Gomella LG, Talor E, Winship MD, Spitler LE, Mastrangelo MJ. Immunologic approaches to the treatment of prostate cancer. Semin Oncol. 1999 Aug; 26(4):439-47. PMID: 10482186.
      Citations:    
    102. Harris DT, Sakiestewa D, Lyons C, Kreitman RJ, Pastan I. Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor. Bone Marrow Transplant. 1999 Jan; 23(2):137-44. PMID: 10197798.
      Citations:    
    103. Harris DT, Sakiestewa D, Robledo RF, Witten M. Short-term exposure to JP-8 jet fuel results in long-term immunotoxicity. Toxicol Ind Health. 1997 Sep-Oct; 13(5):559-70. PMID: 9284530.
      Citations:    
    104. Harris DT, Sakiestewa D, Robledo RF, Witten M. Protection from JP-8 jet fuel induced immunotoxicity by administration of aerosolized substance P. Toxicol Ind Health. 1997 Sep-Oct; 13(5):571-88. PMID: 9284531.
      Citations:    
    105. Rubin J, Galanis E, Pitot HC, Richardson RL, Burch PA, Charboneau JW, Reading CC, Lewis BD, Stahl S, Akporiaye ET, Harris DT. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Ther. 1997 May; 4(5):419-25. PMID: 9274718.
      Citations:    
    106. Stopeck AT, Hersh EM, Akporiaye ET, Harris DT, Grogan T, Unger E, Warneke J, Schluter SF, Stahl S. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J Clin Oncol. 1997 Jan; 15(1):341-9. PMID: 8996161.
      Citations:    
    107. Harris DT, Sakiestewa D, Robledo RF, Witten M. Immunotoxicological effects of JP-8 jet fuel exposure. Toxicol Ind Health. 1997 Jan-Feb; 13(1):43-55. PMID: 9098949.
      Citations:    
    108. Tsang TC, Harris DT, Akporiaye ET, Chu RS, Brailey J, Liu F, Vasanwala FH, Schluter SF, Hersh EM. Mammalian expression vector with two multiple cloning sites for expression of two foreign genes. Biotechniques. 1997 Jan; 22(1):68. PMID: 8994649.
      Citations:    
    109. Harris DT. Experience in autologous and allogeneic cord blood banking. J Hematother. 1996 Apr; 5(2):123-8. PMID: 8723787.
      Citations:    
    110. Tsang TC, Harris DT, Akporiaye ET, Schluter SF, Bowden GT, Hersh EM. Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sites. Biotechniques. 1996 Jan; 20(1):51-2. PMID: 8770406.
      Citations:    
    111. Harris DT. Adjuvant systemic therapy for breast cancer. Semin Oncol. 1995 Dec; 22(6):553-70. PMID: 8539632.
      Citations:    
    112. Harris DT. Introduction: adjuvant and neoadjuvant therapy. Semin Oncol. 1995 Dec; 22(6):529. PMID: 8539629.
      Citations:    
    113. Kapur R, Evans DL, Harris DT. An evolutionary conserved target cell antigen along with MHC class I molecules influences susceptibility to murine NK cell lysis. Dev Comp Immunol. 1995 Jul-Aug; 19(4):347-55. PMID: 8617405.
      Citations:    
    114. Friend PJ, Rebello P, Oliveira D, Manna V, Cobbold SP, Hale G, Jamieson NV, Jamieson I, Calne RY, Harris DT, et al. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Transplant Proc. 1995 Feb; 27(1):869-70. PMID: 7879212.
      Citations:    
    115. Harris DT. In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood. Bone Marrow Transplant. 1995 Jan; 15(1):17-23. PMID: 7742753.
      Citations:    
    116. Harris DT, LoCascio J, Besencon FJ. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant. 1994 Oct; 14(4):545-53. PMID: 7858529.
      Citations:    
    117. Harris DT, Schumacher MJ, LoCascio J, Booth A, Bard J, Boyse EA. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantation. Bone Marrow Transplant. 1994 Jul; 14(1):63-8. PMID: 7951121.
      Citations:    
    118. Kapur R, Evans DL, Harris DT. Evolutionary conservation of a human function-associated molecule on murine natural killer cells: expression and function. Scand J Immunol. 1994 Jul; 40(1):50-6. PMID: 8029643.
      Citations:    
    119. Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein P, Bard J, Boyse EA. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994 Feb; 13(2):135-43. PMID: 8205082.
      Citations:    
    120. Harris DT. Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia. Blood Cells. 1994; 20(2-3):560-4; discussion 564-5. PMID: 7749121.
      Citations:    
    121. Harris DT, Jaso-Friedmann L, Evans DL. Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules. Scand J Immunol. 1994 Jan; 39(1):73-8. PMID: 8290895.
      Citations:    
    122. Yeoman H, Gress RE, Bare CV, Leary AG, Boyse EA, Bard J, Shultz LD, Harris DT, DeLuca D. Human bone marrow and umbilical cord blood cells generate CD4+ and CD8+ single-positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci U S A. 1993 Nov 15; 90(22):10778-82. PMID: 7902570.
      Citations:    
    123. Harris DT, Camenisch TD, Jaso-Friedmann L, Evans DL. Expression of an evolutionarily conserved function associated molecule on sheep, horse and cattle natural killer cells. Vet Immunol Immunopathol. 1993 Oct; 38(3-4):273-82. PMID: 8291205.
      Citations:    
    124. Harris DT, Jaso-Friedmann L, Evans DL. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes. Immunol Lett. 1993 Sep; 38(1):11-8. PMID: 8300148.
      Citations:    
    125. Harris DT. Prophylactic cranial irradiation in small-cell lung cancer. Semin Oncol. 1993 Aug; 20(4):338-50. PMID: 8393592.
      Citations:    
    126. Camenisch TD, Jaso-Friedmann L, Evans DL, Harris DT. Expression of a novel function-associated molecule on cells mediating spontaneous cytolysis in swine. Dev Comp Immunol. 1993 May-Jun; 17(3):277-82. PMID: 8325438.
      Citations:    
    127. Harris DT, LoCascio J, Acevedo A, Olson GB, Bard J, Boyse EA. Analysis of the hairless mouse as a model for the effects of aging on the immune system. Immunol Lett. 1993 Apr; 36(1):19-26. PMID: 8344713.
      Citations:    
    128. Evans DL, Harris DT, Leary JH, St John AL, Jaso-Friedman L. Identification of a vimentin-like function associated molecule (FAM) on rat NK cells: evidence for receptor function. Scand J Immunol. 1993 Feb; 37(2):131-42. PMID: 8434225.
      Citations:    
    129. Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, Shenker L, Bard J, Boyse EA. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A. 1992 Nov 01; 89(21):10006-10. PMID: 1438190.
      Citations:    
    130. Harris DT, Kapur R, Frye C, Acevedo A, Camenisch T, Jaso-Friedmann L, Evans DL. A species-conserved NK cell antigen receptor is a novel vimentin-like molecule. Dev Comp Immunol. 1992 Sep-Oct; 16(5):395-403. PMID: 1426491.
      Citations:    
    131. Evans DL, Harris DT, Leary J, Jaso-Friedmann L. A function-associated molecule on rat natural killer cells identified by anti-idiotypic monoclonal antibodies. Cell Immunol. 1992 May; 141(2):293-305. PMID: 1576653.
      Citations:    
    132. Jaso-Friedmann L, Leary JH, St John AL, Harris DT, Koren HS, Evans DL. Detection of function-associated molecules on rat NK cells and their role in target cell lysis. Cell Immunol. 1992 Apr 15; 141(1):131-47. PMID: 1555247.
      Citations:    
    133. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL. The natural killer cell-like lytic activity expressed by cytolytic T lymphocytes is associated with the expression of a novel function-associated molecule. Scand J Immunol. 1992 Mar; 35(3):299-309. PMID: 1531548.
      Citations:    
    134. Harris DT, Mastrangelo MJ. Theory and application of early systemic therapy. Semin Oncol. 1991 Dec; 18(6):493-503. PMID: 1775968.
      Citations:    
    135. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL. Identification of an evolutionarily conserved, function-associated molecule on human natural killer cells. Proc Natl Acad Sci U S A. 1991 Apr 15; 88(8):3009-13. PMID: 2014223.
      Citations:    
    136. Becker S, Harris DT, Koren HS. Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines. Am J Respir Cell Mol Biol. 1990 Nov; 3(5):441-8. PMID: 2145881.
      Citations:    
    137. Jaso-Friedmann L, Harris DT, St John A, Koren HS, Evans DL. A monoclonal antibody-purified soluble target cell antigen inhibits nonspecific cytotoxic cell activity. J Immunol. 1990 Mar 15; 144(6):2413-8. PMID: 1690243.
      Citations:    
    138. Evans DL, Harris DT, Staton DL, Jaso-Friedmann L. Detection of function-associated molecules on rat leukemic NK cells: activation by monoclonal antibody or phorbol ester. Nat Immun Cell Growth Regul. 1990; 9(6):353-65. PMID: 2087244.
      Citations:    
    139. Harris DT, Travis WW, Koren HS. Induction of activation antigens on human natural killer cells mediated through the Fc-gamma receptor. J Immunol. 1989 Oct 01; 143(7):2401-6. PMID: 2528593.
      Citations:    
    140. Harris DT, Mastrangelo MJ. Serotherapy of cancer. Semin Oncol. 1989 Jun; 16(3):180-98. PMID: 2658082.
      Citations:    
    141. Jaso-Friedmann L, Evans DL, Grant CC, St John A, Harris DT, Koren HS. Characterization by monoclonal antibodies of a target cell antigen complex recognized by nonspecific cytotoxic cells. J Immunol. 1988 Oct 15; 141(8):2861-8. PMID: 2459231.
      Citations:    
    142. Evans DL, Jaso-Friedmann L, Smith EE, St John A, Koren HS, Harris DT. Identification of a putative antigen receptor on fish nonspecific cytotoxic cells with monoclonal antibodies. J Immunol. 1988 Jul 01; 141(1):324-32. PMID: 2454262.
      Citations:    
    143. Harris DT, Kozumbo WJ, Testa JE, Cerutti PA, Cerottini JC. Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes. J Immunol. 1988 Feb 01; 140(3):921-7. PMID: 3276784.
      Citations:    
    144. Harris DT, Kozumbo WJ, Cerutti PA, Cerottini JC. Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes. Cell Immunol. 1987 Oct 01; 109(1):104-14. PMID: 3115596.
      Citations:    
    145. Harris DT, Iglesias JL, Argov S, Toomey J, Koren HS. Heterogeneity of human natural killer (NK) cells: enrichment of NK by negative-selection with the lectin from Erythrina cristagalli. J Leukoc Biol. 1987 Aug; 42(2):163-70. PMID: 3474339.
      Citations:    
    146. Kozumbo WJ, Harris DT, Gromkowski S, Cerottini JC, Cerutti PA. Molecular mechanisms involved in T cell activation. II. The phosphatidylinositol signal-transducing mechanism mediates antigen-induced lymphokine production but not interleukin 2-induced proliferation in cloned cytotoxic T lymphocytes. J Immunol. 1987 Jan 15; 138(2):606-12. PMID: 3540124.
      Citations:    
    147. Harris DT, Kozumbo WJ, Cerutti P, Cerottini JC. Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes. J Immunol. 1987 Jan 15; 138(2):600-5. PMID: 3540123.
      Citations:    
    148. Harris DT, Sekaly RP. Target cell susceptibility to immune lysis and expression of MHC antigens are independent of position in the cell cycle. J Immunol. 1984 Jul; 133(1):40-4. PMID: 6427344.
      Citations:    
    149. Harris DT, MacDonald HR, Cerottini JC. Antigen recognition by H-2-restricted cytolytic T lymphocytes is not mediated by two independent receptors. J Exp Med. 1984 Jan 01; 159(1):330-5. PMID: 6198426.
      Citations:    
    150. Harris DT, MacDonald HR, Cerottini JC. Direct transfer of antigen-specific cytolytic activity to noncytolytic cells upon fusion with liposomes derived from cytolytic T cell clones. J Exp Med. 1984 Jan 01; 159(1):261-75. PMID: 6198423.
      Citations:    
    151. Harris DT, Maguire HC. Renal-cell carcinoma. Introduction. Semin Oncol. 1983 Dec; 10(4):365. PMID: 6665564.
      Citations:    
    152. Harris DT. Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol. 1983 Dec; 10(4):422-30. PMID: 6320451.
      Citations:    
    153. Ruebush MJ, Hale AH, Lefrancois L, Harris DT, Burgess DE. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes. J Immunol. 1981 May; 126(5):2053-9. PMID: 6260862.
      Citations:    
    154. Harris DT, Hale AH, Lefrancois L. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes. J Immunol. 1981 May; 126(5):1914-8. PMID: 6260860.
      Citations:    
    155. Ruebush MJ, Hale AH, Harris DT. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles. Infect Immun. 1981 May; 32(2):513-7. PMID: 6265359.
      Citations:    
    156. Hale AH, Ruebush MJ, Harris DT, McGee MP. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells. J Immunol. 1981 Apr; 126(4):1485-8. PMID: 6970778.
      Citations:    
    157. Hale AH, Ruebush MJ, Lyles DS, Harris DT. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1980 Oct; 77(10):6105-8. PMID: 6255476.
      Citations:    
    Harris's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (638)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _